Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ghazaleh Sadri-Vakili, Ph.D.

Title
Institution
Department
Address
Phone

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Bedlack RS, Wicks P, Vaughan T, Opie A, Blum R, Dios A, Sadri-Vakili G. Lunasin does not slow ALS progression: results of an open-label, single-center, hybrid-virtual 12-month trial. Amyotroph Lateral Scler Frontotemporal Degener. 2019 Jan 21; 1-9. PMID: 30663902.
    Citations:    Fields:    
  2. Mueller KA, Glajch KE, Huizenga MN, Wilson RA, Granucci EJ, Dios AM, Tousley AR, Iuliano M, Weisman E, LaQuaglia MJ, DiFiglia M, Kegel-Gleason K, Vakili K, Sadri-Vakili G. Hippo Signaling Pathway Dysregulation in Human Huntington's Disease Brain and Neuronal Stem Cells. Sci Rep. 2018 Jul 27; 8(1):11355. PMID: 30054496.
    Citations:    Fields:    
  3. Bakshi R, Xu Y, Mueller KA, Chen X, Granucci E, Paganoni S, Sadri-Vakili G, Schwarzschild MA. Urate mitigates oxidative stress and motor neuron toxicity of astrocytes derived from ALS-linked SOD1G93A mutant mice. Mol Cell Neurosci. 2018 10; 92:12-16. PMID: 29928993.
    Citations:    Fields:    
  4. McCarthy DM, Mueller KA, Cannon EN, Huizenga MN, Darnell SB, Bhide PG, Sadri-Vakili G. Prenatal Cocaine Exposure Alters BDNF-TrkB Signaling in the Embryonic and Adult Brain. Dev Neurosci. 2016; 38(5):365-374. PMID: 28132054.
    Citations: 1     Fields:    Translation:AnimalsCells
  5. McCarthy DM, Bell GA, Cannon EN, Mueller KA, Huizenga MN, Sadri-Vakili G, Fadool DA, Bhide PG. Reversal Learning Deficits Associated with Increased Frontal Cortical Brain-Derived Neurotrophic Factor Tyrosine Kinase B Signaling in a Prenatal Cocaine Exposure Mouse Model. Dev Neurosci. 2016; 38(5):354-364. PMID: 27951531.
    Citations: 2     Fields:    Translation:AnimalsCells
  6. Glajch KE, Ferraiuolo L, Mueller KA, Stopford MJ, Prabhkar V, Gravanis A, Shaw PJ, Sadri-Vakili G. MicroNeurotrophins Improve Survival in Motor Neuron-Astrocyte Co-Cultures but Do Not Improve Disease Phenotypes in a Mutant SOD1 Mouse Model of Amyotrophic Lateral Sclerosis. PLoS One. 2016; 11(10):e0164103. PMID: 27716798.
    Citations: 1     Fields:    Translation:HumansAnimalsCells
  7. LaQuaglia MJ, Grijalva JL, Mueller KA, Perez-Atayde AR, Kim HB, Sadri-Vakili G, Vakili K. YAP Subcellular Localization and Hippo Pathway Transcriptome Analysis in Pediatric Hepatocellular Carcinoma. Sci Rep. 2016 09 08; 6:30238. PMID: 27605415.
    Citations: 9     Fields:    Translation:HumansCells
  8. Batalha VL, Ferreira DG, Coelho JE, Valadas JS, Gomes R, Temido-Ferreira M, Shmidt T, Baqi Y, Buée L, Müller CE, Hamdane M, Outeiro TF, Bader M, Meijsing SH, Sadri-Vakili G, Blum D, Lopes LV. The caffeine-binding adenosine A2A receptor induces age-like HPA-axis dysfunction by targeting glucocorticoid receptor function. Sci Rep. 2016 08 11; 6:31493. PMID: 27510168.
    Citations: 10     Fields:    Translation:HumansAnimalsCells
  9. Vodicka P, Mo S, Tousley A, Green KM, Sapp E, Iuliano M, Sadri-Vakili G, Shaffer SA, Aronin N, DiFiglia M, Kegel-Gleason KB. Mass Spectrometry Analysis of Wild-Type and Knock-in Q140/Q140 Huntington's Disease Mouse Brains Reveals Changes in Glycerophospholipids Including Alterations in Phosphatidic Acid and Lyso-Phosphatidic Acid. J Huntingtons Dis. 2015; 4(2):187-201. PMID: 26397899.
    Citations: 1     Fields:    Translation:AnimalsCells
  10. Glajch KE, Sadri-Vakili G. Epigenetic Mechanisms Involved in Huntington's Disease Pathogenesis. J Huntingtons Dis. 2015; 4(1):1-15. PMID: 25813218.
    Citations: 7     Fields:    Translation:HumansAnimalsCells
  11. Satterlee JS, Basanta-Sanchez M, Blanco S, Li JB, Meyer K, Pollock J, Sadri-Vakili G, Rybak-Wolf A. Novel RNA modifications in the nervous system: form and function. J Neurosci. 2014 Nov 12; 34(46):15170-7. PMID: 25392485; PMCID: PMC4402329.
    Citations: 7     Fields:    Translation:HumansAnimalsCells
  12. Schmidt HD, McFarland KN, Darnell SB, Huizenga MN, Sangrey GR, Cha JH, Pierce RC, Sadri-Vakili G. ADAR2-dependent GluA2 editing regulates cocaine seeking. Mol Psychiatry. 2015 Nov; 20(11):1460-6. PMID: 25349168.
    Citations: 9     Fields:    Translation:AnimalsCells
  13. Sadri-Vakili G. Cocaine triggers epigenetic alterations in the corticostriatal circuit. Brain Res. 2015 Dec 02; 1628(Pt A):50-9. PMID: 25301690; PMCID: PMC4387100.
    Citations: 3     Fields:    Translation:HumansAnimals
  14. Rasakham K, Schmidt HD, Kay K, Huizenga MN, Calcagno N, Pierce RC, Spires-Jones TL, Sadri-Vakili G. Synapse density and dendritic complexity are reduced in the prefrontal cortex following seven days of forced abstinence from cocaine self-administration. PLoS One. 2014; 9(7):e102524. PMID: 25072653; PMCID: PMC4114454.
    Citations: 9     Fields:    Translation:AnimalsCells
  15. Grijalva JL, Huizenga M, Mueller K, Rodriguez S, Brazzo J, Camargo F, Sadri-Vakili G, Vakili K. Dynamic alterations in Hippo signaling pathway and YAP activation during liver regeneration. Am J Physiol Gastrointest Liver Physiol. 2014 Jul 15; 307(2):G196-204. PMID: 24875096.
    Citations: 32     Fields:    Translation:AnimalsCells
  16. Licata SC, Shinday NM, Huizenga MN, Darnell SB, Sangrey GR, Rudolph U, Rowlett JK, Sadri-Vakili G. Alterations in brain-derived neurotrophic factor in the mouse hippocampus following acute but not repeated benzodiazepine treatment. PLoS One. 2013; 8(12):e84806. PMID: 24367698; PMCID: PMC3868703.
    Citations: 4     Fields:    Translation:Animals
  17. McFarland KN, Huizenga MN, Darnell SB, Sangrey GR, Berezovska O, Cha JH, Outeiro TF, Sadri-Vakili G. MeCP2: a novel Huntingtin interactor. Hum Mol Genet. 2014 Feb 15; 23(4):1036-44. PMID: 24105466; PMCID: PMC3900110.
    Citations: 10     Fields:    Translation:HumansAnimalsCells
  18. Vassoler FM, Sadri-Vakili G. Mechanisms of transgenerational inheritance of addictive-like behaviors. Neuroscience. 2014 Apr 04; 264:198-206. PMID: 23920159; PMCID: PMC3872494.
    Citations: 19     Fields:    Translation:HumansAnimals
  19. Vashishtha M, Ng CW, Yildirim F, Gipson TA, Kratter IH, Bodai L, Song W, Lau A, Labadorf A, Vogel-Ciernia A, Troncosco J, Ross CA, Bates GP, Krainc D, Sadri-Vakili G, Finkbeiner S, Marsh JL, Housman DE, Fraenkel E, Thompson LM. Targeting H3K4 trimethylation in Huntington disease. Proc Natl Acad Sci U S A. 2013 Aug 06; 110(32):E3027-36. PMID: 23872847; PMCID: PMC3740882.
    Citations: 33     Fields:    Translation:HumansAnimalsCells
  20. Schmidt HD, McGinty JF, West AE, Sadri-Vakili G. Epigenetics and psychostimulant addiction. Cold Spring Harb Perspect Med. 2013 Mar 01; 3(3):a012047. PMID: 23359110; PMCID: PMC3579203.
    Citations: 24     Fields:    Translation:HumansCells
  21. McFarland KN, Das S, Sun TT, Leyfer D, Kim MO, Xia E, Sangrey GR, Kuhn A, Luthi-Carter R, Clark TW, Sadri-Vakili G, Cha JH. Genome-wide increase in histone H2A ubiquitylation in a mouse model of Huntington's disease. J Huntingtons Dis. 2013; 2(3):263-77. PMID: 25062675.
    Citations: 2     Fields:    Translation:AnimalsCells
  22. Vassoler FM, White SL, Schmidt HD, Sadri-Vakili G, Pierce RC. Epigenetic inheritance of a cocaine-resistance phenotype. Nat Neurosci. 2013 Jan; 16(1):42-7. PMID: 23242310; PMCID: PMC3531046.
    Citations: 89     Fields:    Translation:AnimalsCells
  23. McFarland KN, Das S, Sun TT, Leyfer D, Xia E, Sangrey GR, Kuhn A, Luthi-Carter R, Clark TW, Sadri-Vakili G, Cha JH. Genome-wide histone acetylation is altered in a transgenic mouse model of Huntington's disease. PLoS One. 2012; 7(7):e41423. PMID: 22848491; PMCID: PMC3407195.
    Citations: 18     Fields:    Translation:AnimalsCells
  24. Jia H, Pallos J, Jacques V, Lau A, Tang B, Cooper A, Syed A, Purcell J, Chen Y, Sharma S, Sangrey GR, Darnell SB, Plasterer H, Sadri-Vakili G, Gottesfeld JM, Thompson LM, Rusche JR, Marsh JL, Thomas EA. Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington's disease. Neurobiol Dis. 2012 May; 46(2):351-61. PMID: 22590724; PMCID: PMC3528106.
    Citations: 41     Fields:    Translation:HumansAnimalsCells
  25. Ritch JJ, Valencia A, Alexander J, Sapp E, Gatune L, Sangrey GR, Sinha S, Scherber CM, Zeitlin S, Sadri-Vakili G, Irimia D, Difiglia M, Kegel KB. Multiple phenotypes in Huntington disease mouse neural stem cells. Mol Cell Neurosci. 2012 May; 50(1):70-81. PMID: 22508027; PMCID: PMC3383872.
    Citations: 17     Fields:    Translation:AnimalsCells
  26. Schmidt HD, Sangrey GR, Darnell SB, Schassburger RL, Cha JH, Pierce RC, Sadri-Vakili G. Increased brain-derived neurotrophic factor (BDNF) expression in the ventral tegmental area during cocaine abstinence is associated with increased histone acetylation at BDNF exon I-containing promoters. J Neurochem. 2012 Jan; 120(2):202-9. PMID: 22043863; PMCID: PMC3243782.
    Citations: 31     Fields:    Translation:AnimalsCells
  27. McCarthy DM, Zhang X, Darnell SB, Sangrey GR, Yanagawa Y, Sadri-Vakili G, Bhide PG. Cocaine alters BDNF expression and neuronal migration in the embryonic mouse forebrain. J Neurosci. 2011 Sep 21; 31(38):13400-11. PMID: 21940433; PMCID: PMC3182852.
    Citations: 16     Fields:    Translation:AnimalsCells
  28. Sadri-Vakili G, Kumaresan V, Schmidt HD, Famous KR, Chawla P, Vassoler FM, Overland RP, Xia E, Bass CE, Terwilliger EF, Pierce RC, Cha JH. Cocaine-induced chromatin remodeling increases brain-derived neurotrophic factor transcription in the rat medial prefrontal cortex, which alters the reinforcing efficacy of cocaine. J Neurosci. 2010 Sep 01; 30(35):11735-44. PMID: 20810894; PMCID: PMC2943400.
    Citations: 72     Fields:    Translation:AnimalsCells
  29. Benn CL, Luthi-Carter R, Kuhn A, Sadri-Vakili G, Blankson KL, Dalai SC, Goldstein DR, Spires TL, Pritchard J, Olson JM, van Dellen A, Hannan AJ, Cha JH. Environmental enrichment reduces neuronal intranuclear inclusion load but has no effect on messenger RNA expression in a mouse model of Huntington disease. J Neuropathol Exp Neurol. 2010 Aug; 69(8):817-27. PMID: 20613636.
    Citations: 7     Fields:    Translation:AnimalsCells
  30. Famous KR, Kumaresan V, Sadri-Vakili G, Schmidt HD, Mierke DF, Cha JH, Pierce RC. Phosphorylation-dependent trafficking of GluR2-containing AMPA receptors in the nucleus accumbens plays a critical role in the reinstatement of cocaine seeking. J Neurosci. 2008 Oct 22; 28(43):11061-70. PMID: 18945913; PMCID: PMC2601563.
    Citations: 55     Fields:    Translation:AnimalsCells
  31. Benn CL, Sun T, Sadri-Vakili G, McFarland KN, DiRocco DP, Yohrling GJ, Clark TW, Bouzou B, Cha JH. Huntingtin modulates transcription, occupies gene promoters in vivo, and binds directly to DNA in a polyglutamine-dependent manner. J Neurosci. 2008 Oct 15; 28(42):10720-33. PMID: 18923047; PMCID: PMC2586288.
    Citations: 64     Fields:    Translation:HumansAnimalsCells
  32. Sadri-Vakili G, Janis GC, Pierce RC, Gibbs TT, Farb DH. Nanomolar concentrations of pregnenolone sulfate enhance striatal dopamine overflow in vivo. J Pharmacol Exp Ther. 2008 Dec; 327(3):840-5. PMID: 18772319; PMCID: PMC2864155.
    Citations: 7     Fields:    Translation:AnimalsCells
  33. Broom WJ, Greenway M, Sadri-Vakili G, Russ C, Auwarter KE, Glajch KE, Dupre N, Swingler RJ, Purcell S, Hayward C, Sapp PC, McKenna-Yasek D, Valdmanis PN, Bouchard JP, Meininger V, Hosler BA, Glass JD, Polack M, Rouleau GA, Cha JH, Hardiman O, Brown RH. 50bp deletion in the promoter for superoxide dismutase 1 (SOD1) reduces SOD1 expression in vitro and may correlate with increased age of onset of sporadic amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2008 Aug; 9(4):229-37. PMID: 18608091.
    Citations: 7     Fields:    Translation:HumansCells
  34. Kim MO, Chawla P, Overland RP, Xia E, Sadri-Vakili G, Cha JH. Altered histone monoubiquitylation mediated by mutant huntingtin induces transcriptional dysregulation. J Neurosci. 2008 Apr 09; 28(15):3947-57. PMID: 18400894; PMCID: PMC3844822.
    Citations: 19     Fields:    Translation:AnimalsCells
  35. Anderson SM, Famous KR, Sadri-Vakili G, Kumaresan V, Schmidt HD, Bass CE, Terwilliger EF, Cha JH, Pierce RC. CaMKII: a biochemical bridge linking accumbens dopamine and glutamate systems in cocaine seeking. Nat Neurosci. 2008 Mar; 11(3):344-53. PMID: 18278040.
    Citations: 138     Fields:    Translation:AnimalsCells
  36. Kim, M., Chawla, P., Overland, R.P., E. Xia, Sadri-Vakili, G., Cha, J.-H.J. Mutant Huntingtin-mediated histone monoubiquitylation induces transcriptional dysregulation in Huntington’s disease. Journal of Neuroscience. 2008; in press.
  37. Broom, W.J., Greenway, M., Sadri-Vakili, G., Russ, C., Auwrter, K.E., Glajch, K.E., Swingler, R.J., Purcell, S., Sapp, P.C., McKenna-Yasek, D., Hosler, B.A., Horvitz, H.R., Glass, J.D., Cha, J.H.J., Hardiman, O., Brown Jr., R.H. 50bp deletion in the promoter for SOD1 promoter reduces SOD1 expression in vitro and correlates with population-specific increased age of onset in sporadic ALS. Amyotrophic Lateral Sclerosis. 2008; in press.
  38. Sadri-Vakili, G. Histones Associated with Downregulated Genes are Hypo-acetylated in Huntington’s Disease Models. 2008.
  39. Benn, C.L. and Sadri-Vakili, G. Misfolded huntingtin protein and implications for transcriptional dysregulation. Protein Misfolding in Biology and Disease. 2008; in press.
  40. Sadri-Vakili G, Bouzou B, Benn CL, Kim MO, Chawla P, Overland RP, Glajch KE, Xia E, Qiu Z, Hersch SM, Clark TW, Yohrling GJ, Cha JH. Histones associated with downregulated genes are hypo-acetylated in Huntington's disease models. Hum Mol Genet. 2007 Jun 01; 16(11):1293-306. PMID: 17409194.
    Citations: 62     Fields:    Translation:AnimalsCells
  41. Sadri-Vakili, G., Bouzou, B., Benn, C.L., Kim, M., Chawla, P., Overland, R.P., Glajch, K.E., Xia, E., Qui, Z., Hersch, S.M., Clark, T.W., Yohrling, G.J., Cha, J.-H.J. Histones Associated with Downregulated Genes are Hypo-acetylated in Huntington’s Disease Models. Gordon Conference on CAG triplet repeat disorders. 2007.
  42. Sadri-Vakili, G. Epigenetics of cocaine addiction. 40th Winter Conference on Brain Research. 2007.
  43. Cha, J.-H.J., Bouzou, B., Benn, C.L., Kim, M., Chawla, P., Overland, R.P., Glajch, K.E., Xia, E., Qui, Z., Hersch, S.M., Clark, T.W., Yohrling, G.J., Sadri-Vakili, G. . Histones Associated with Downregulated Genes are Hypo-acetylated in Huntington’s Disease Models. Society for Neuroscience 37th Annual Meeting. 2007.
  44. Famous, K.R., Sadri-Vakili, G., Kumaresan, V., Schmidt, H.D., Cha, J.-H.J., Pierce, R.C. Increased transcription of CaM-KII in the rat medial prefrontal cortex promotes the reinstatement of cocaine-seeking behavior. Society for Neuroscience 37th Annual Meeting. 2007.
  45. Kim, M., Chawla, P., Ovelnand, R.P., Sadri-Vakili, G., Cha, J.-H.J. . Mutant huntingtin mediated histone monoubiquitylation induces transcriptional dysregulation in Huntington’s disease. Society for Neuroscience 37th Annual Meeting. 2007.
  46. Sadri-Vakili, G., Kumaresan, V., Famous, K.R., Overland, R.P., Xia, E., Schmidt, H.D., Pierce, R.C., Cha, J.-H.J. . Epigenetic regulation of cocaine-induced increases in Brain-derived Neurotrophic Factor transcript in the medial Prefrontal Cortex of the rat. Society for Neurosceince 37th Annual Meeting. 2007.
  47. Benn, C.L., Sun, T., Sadri-Vakili, G., Overland, R.P., Vasan, A., DiRocco, D.P., Yohrling, G.J., Clark, T.W., Bouzou, B., Cha, J.-H.J. . Huntingtin modulates transcription, occupies gene promoters in vivo and binds directly to DNA in a polyglutamine dependent manner. Society for Neuroscience 37th Annual Meeting. 2007.
  48. Sadri-Vakili G, Cha JH. Histone deacetylase inhibitors: a novel therapeutic approach to Huntington's disease (complex mechanism of neuronal death). Curr Alzheimer Res. 2006 Sep; 3(4):403-8. PMID: 17017871.
    Citations: 18     Fields:    Translation:HumansAnimalsCells
  49. Sadri-Vakili, G., Chawla, P., Glajch, K.E., Overland, R.P., Cha, J.-H.J. . Histones associated with downregulated genes are hypo-acetylated in in vitro models of Huntington’s disease. HD 2006: Changes, Advances, and good news (CAG)n. 2006.
  50. Sadri-Vakili G, Menon AS, Farrell LA, Keller-McGandy CE, Cantuti-Castelvetri I, Standaert DG, Augood SJ, Yohrling GJ, Cha JH. Huntingtin inclusions do not down-regulate specific genes in the R6/2 Huntington's disease mouse. Eur J Neurosci. 2006 Jun; 23(12):3171-5. PMID: 16820007.
    Citations: 11     Fields:    Translation:HumansAnimalsCells
  51. Sadri-Vakili G, Cha JH. Mechanisms of disease: Histone modifications in Huntington's disease. Nat Clin Pract Neurol. 2006 Jun; 2(6):330-8. PMID: 16932577.
    Citations: 35     Fields:    Translation:HumansCells
  52. Chen-Plotkin AS, Sadri-Vakili G, Yohrling GJ, Braveman MW, Benn CL, Glajch KE, DiRocco DP, Farrell LA, Krainc D, Gines S, MacDonald ME, Cha JH. Decreased association of the transcription factor Sp1 with genes downregulated in Huntington's disease. Neurobiol Dis. 2006 May; 22(2):233-41. PMID: 16442295.
    Citations: 44     Fields:    Translation:HumansAnimalsCells
  53. Cha, J.-H.J., Benn, C.L., Chawla, P., Glajch, K.E., Kim, M., Overland, R.P., Sadri-Vakili, G., Sun, T. . Mechanisms of transcriptional dysregulation in Huntington’s disease. Society for Neurosceince 35th Annual Meeting. 2005.
  54. Sadri-Vakili, G., Chawla, P., Glajch, K.E., Overland, R.P., Cha, J.-H.J. . Histone modifications in Huntington’s disease. Society for Neurosceince 35th Annual Meeting,. 2005.
  55. Sadri-Vakili, G., Chawla, P., Glajch, K.E., Overland, R.P., Cha, J.-H.J. . Histone modifications in Huntington’s disease. American Neurological Association 130th Annual Meeting, plenary talk. 2005.
  56. Sadri-Vakili, G., Chawla, P., Glajch, K.E., Overland, R.P., Cha, J.-H.J. Histone modifications in Huntington’s disease. Gordon Research Conference, CAG triplet repeat disorders. 2005.
  57. Sadri-Vakili, G., Farrell, L.A., Penney E.B., Cha, J.-H.J. . Analysis of histone modifications in Huntington’s disease. Society for Neurosceince 34th Annual Meeting,. 2004.
  58. Norflus, F., Chopra, V., Singh, B., Chopra, R., Swindell, K., Fox, J., Sadri-Vakili, G., Farrell, L.A., Cha, J.-H.J., Ryu, H., Ferrante, R.J., Hersch, S.M. . 5-AZA-2’-Deoxycytidine is neuroprotective in N171-82Q and R6/2 Huntington’s disease transgenic mice. HDSA coalition for the cure 8th Annual Meeting,. 2004.
  59. Sadri-Vakili, G., Farrell, L.A., Penney E.B., Cha, J.-H.J. Analysis of histone modifications in Huntington’s disease. HDSA coalition for the cure 8th Annual Meeting,. 2004.
  60. Sadri-Vakili, G., Farrell, L.A., Penney E.B., Cha, J.-H.J. . Analysis of histone modifications in Huntington’s disease. HDF 2004: Changes, Advances, and good news (CAG)n. 2004.
  61. Farb, David H., Sadri-Vakili, Ghazaleh; Pierce, Robert Christopher; Johnson, David W; Gibbs, Terrell T. Neuroactive steroid derivatives and method of use. 2004.
  62. Sadri-Vakili, G., Penney, E.B., Farrell, L.A., Braveman, M.W., Cha, J.-H.J. . Chromatin Immunoprecipitation analysis of histone modificaitons in Huntington’s disease. Society for Neuroscience 33rd Annual Meeting,. 2003.
  63. Sadri-Vakili G, Johnson DW, Janis GC, Gibbs TT, Pierce RC, Farb DH. Inhibition of NMDA-induced striatal dopamine release and behavioral activation by the neuroactive steroid 3alpha-hydroxy-5beta-pregnan-20-one hemisuccinate. J Neurochem. 2003 Jul; 86(1):92-101. PMID: 12807429.
    Citations: 3     Fields:    Translation:Animals
  64. Ghazaleh Sadri-Vakili. Neurosteroids modulate ionotropic glutamate receptor-induced dopamine release and locomotor acticity in the rat. 2003.
  65. Sadri-Vakili, G., Janis, G.C., Gibbs, T.T., Pierce, R.C., and Farb, D.H. . Pregnenolone sulfate increases dopamine release in the rat striatum. Society for Neuroscience 32th Annual Meeting,. 2002.
  66. Sadri-Vakili, G., Janis, G.C., Johnson, D.W., Pierce, R.C., and Farb, D.H. . Inhibition of NMDA-induced striatal dopamine release and behavioral activation by the neuroactive steroid 3?-Hydroxy-5?-Pregnan-20-One Hemisuccinate. 30th New England Pharmacologist Meeting,. 2001.
  67. Sadri, G., Johnson, D.W., Janis, G.C., Gibbs, T.T., Pierce, R.C., and Farb, D.H. . Inhibition of dopamine release through modulation of excitatory amino acid receptors by a neuroactive steroid. Society for Neuroscience 30th Annual Meeting,. 2000.
  68. Sadri, G., Johnson, D.W., Janis, G.C., Pierce, R.C., and Farb, D.H. Neurosteroids modulate excitatory amino acid receptor-mediated dopamine release in the striatum of awake rats. American Society for Pharmacology and Experimental Therapeutics Meeting,. 2000.
  69. Sadri, G., Johnson, D.W., Janis, G.C., Pierce, R.C., and Farb, D.H. Neurosteroids modulate excitatory amino acid receptor-mediated dopamine release in the striatum of awake rats. 6th Annual Russek Student Achievement Day. 2000.
  70. Sadri, G., Johnson, D.W., Janis, G.C., Pierce, R.C., and Farb, D.H. . Neurosteroids modulate excitatory amino acid receptor-mediated dopamine release in the striatum of awake rats. New England Pharmacologists 29th Annual Meeting,. 2000.
  71. Sadri, G., Janis, G.C., Pierce, R.C., Johnson, D.W., and Farb, D.H. Pregnanolone hemisuccinate negatively modulates ionotropic glutamate receptors in the rat striatum as measured by in vivo microdialysis. 5th Annual Russek Student Achievement Day. 1999.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Sadri-Vakili's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (258)
Explore
_
Co-Authors (19)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH/NCATS Clinical and Translational Science Award (CTSA) program, grant number UL1TR001102, and through institutional support from Harvard University, Harvard Medical School, Harvard T.H. Chan School of Public Health, Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Massachusetts General Hospital and the Dana Farber Cancer Institute.